TickerFacts.

Company research / LIVN

LivaNova PLC (LIVN)

Build a valuation ↗↓ Download CSV

CIK 0001639691 · Nasdaq · Electromedical & Electrotherapeutic Apparatus

  • Sector Manufacturing
  • Fiscal year ends around Dec 31

For the year ended 2025-12-31, LivaNova PLC reported revenue of $1.39B. Revenue grew 10.7% from the prior annual period. Over the twelve months to 2026-06-30, revenue was $1.47B.

Key ratios (year ended 2025-12-31)

67.7%
Gross margin (computed)
14.4%
Operating margin
-17.5%
Net margin
-20.2%
Return on year-end equity
10.7%
Revenue growth (YoY)

Computed by TickerFacts from revenue minus cost of revenue. This may differ from the issuer's reported gross profit or margin; check the revenue and cost definitions.

Beyond the statements

Follow the company.

Explore new filings, reported insider transactions and company relationships.

Open company research ↗

Latest selected filing: Form 4 (ownership change) · 2026-09-16

Annual financials

Annual flows and balances are grouped by their actual period end. Select a figure to open its SEC filing. n/a means a matching observation is unavailable. Free cash flow is operating cash flow minus capital expenditures, and EBITDA is operating income plus depreciation and amortization, for the same period, computed by TickerFacts.

The first column covers the twelve months to 2026-06-30 from the latest quarterly report: flows are the last fiscal year plus this year to date minus the same months a year earlier, and balances are as of that date. Per-share figures are annual only.

Period endedTTM to
2026-06-30		2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-31
Revenue$1.47B$1.39B$1.25B$1.15B$1.02B$1.04B$934.24M$1.08B$1.11B$1.01B$964.86M
Cost of Revenue$469.47M$448.18M$399.95M$397.73M$314.58M$329.37M$339.48M$360.37M$361.32M$353.19M$367.85M
Gross Profit (computed)$1.00B$939.87M$853.48M$755.82M$707.23M$705.99M$594.76M$723.80M$745.64M$659.09M$597.01M
R&D Expense$213.06M$185.76M$182.51M$193.82M$155.81M$183.41M$152.90M$146.85M$145.95M$109.52M$82.08M
Operating Income$187.54M$199.39M$129.05M-$68.50M-$76.75M-$784.0K-$273.90M-$171.55M-$248.07M$96.49M$33.45M
Depreciation & Amortizationn/an/an/an/an/an/an/an/an/an/a$85.36M
EBITDAn/an/an/an/an/an/an/an/an/an/a$118.81M
Net Income$188.55M-$242.47M$63.23M$17.55M-$86.25M-$135.82M-$348.82M-$157.64M-$189.40M-$25.09M-$62.79M
EPS (Diluted)n/a-$4.45$1.16$0.32-$1.61-$2.68-$7.18-$3.26-$3.91-$0.52-$1.28
Total Assets$2.64B$2.61B$2.51B$2.43B$2.29B$2.20B$2.40B$2.41B$2.55B$2.50B$2.34B
Total Liabilities$1.32B$1.41B$1.19B$1.15B$1.09B$906.31M$1.29B$1.03B$1.05B$688.58M$635.72M
Long-Term Debt$290.08M$376.06M$626.96M$586.03M$538.96M$236.79M$650.67M$333.51Mn/an/a$122.86M
Shareholders' Equity$1.33B$1.20B$1.32B$1.28B$1.21B$1.29B$1.11B$1.38B$1.50B$1.82B$1.71B
Cash & Equivalents$516.62M$635.55M$428.86M$266.50M$214.17M$207.99M$252.83M$61.14M$47.20M$93.61M$39.79M
Operating Cash Flow$249.26M$254.34M$183.04M$74.91M$69.92M$102.54M-$79.42M-$91.14M$120.49M$91.34M$90.15M
Capital Expenditures$100.95M$81.05M$47.11M$34.98M$26.52M$25.48M$35.02M$24.69M$37.19M$32.93M$38.36M
Free Cash Flow$148.31M$173.29M$135.93M$39.93M$43.40M$77.07M-$114.45M-$115.83M$83.30M$58.41M$51.79M
Share Repurchasesn/an/an/an/an/an/a$0$0$50.00M$0$54.49M
Shares Outstanding55.05M54.65M54.35M53.92M53.56M53.26M48.66M48.44M48.21M48.29M48.03M
Weighted Average Diluted Sharesn/a54.55M54.57M54.21M53.47M50.63M48.59M48.35M48.50M48.50M49.01M
EPS (Basic)n/a-$4.45$1.17$0.33-$1.61-$2.68-$7.18-$3.21-$3.91-$0.52-$1.29

Price chart

Chart and quotes by TradingView. Exchange coverage and delays vary.

Open chart on TradingView